Disparities in Allergy & Asthma Care: Leveling the Playing Field (AAN)

Price: FREE for members and non-members

Session recorded on March 22, 2023
Speaker: Vivian Hernandez-Trujillo, MD

This webinar will focus on the healthcare disparities that Latino/Hispanic patients, both children and adults, face in the areas of asthma and food allergy. Dr. Hernandez-Trujillo will discuss why it is important for allergists to be able to identify the disparities that exist for Latino/Hispanic patients with asthma and/ or food allergy. She will also discuss the need to improve the treatment of asthma and food allergy in patients of Latino/Hispanic ethnicity. Also covered will be how allergists can improve asthma and food allergy disparities by improved recognition in Latino/Hispanic patients. 

Viewers can earn credit by completing the posttest questions.

This program is a collaboration between the American College of Allergy, Asthma & Immunology and the Allergy and Asthma Network.

The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Target Audience

Primary Care Providers
Allied Health Professionals

Learning Objectives

Upon completion of this activity learners should be able to:

  1. Discuss the disparities that exist among Latino/ Hispanic patients with asthma. 
  2. Discuss the disparities that exist among Latino/Hispanic patients with food allergy.  
  3. Describe the effects of food insecurity on patients with food allergy.
Additional information

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all individuals in a position to control or influence the content of an activity must disclose all financial relationships with any ineligible company that have occurred within the past 24 months. The ACCME defines a “ineligible company” as companies whose primary business is producing, marketing, selling, re-selling, or distributing health care goods or services, used by or on patients. Examples of such organizations include: 
•    Advertising, marketing, or communication firms whose clients are ineligible companies
•    Bio-medical startups that have begun a governmental regulatory approval process
•    Compounding pharmacies that manufacture proprietary compounds
•    Device manufacturers or distributors
•    Diagnostic labs that sell proprietary products
•    Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
•    Manufacturers of health-related wearable products
•    Pharmaceutical companies or distributors
•    Pharmacy benefit managers
•    Reagent manufacturers or sellers
The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org. All identified relevant relationships must be mitigated and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure of or absence of relevant financial relationships be provided to the learners prior to the start of the activity.

Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.

Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. All identified relevant financial relationships have been mitigated.

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
Course opens: 
Course expires: 

All identified conflicts of interest have been mitigated.
The individuals listed below disclose the following financial relationships:

Vivian Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI

Advisor: Aimmune, Enzyvant, Sanofi/Regeneron, Takeda

Consultant: Allergy and Asthma Network, Amgen, Kaleo, Pharming

Speaker: CSL Behring, Kaleo, Takeda

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
Please login or create an account to take this course.